Dimension Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Dimension Therapeutics, Inc. reported Increase (Decrease) in Accounts Payable of -$1.34 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2017-11-06
- Dimension Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2017-09-30 was -$304.00K, a 131.83% decline year-over-year.
- Dimension Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2017-06-30 was -$76.00K.
- Dimension Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2017-03-31 was -$957.00K, a 325.71% decline year-over-year.
- Dimension Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2016-12-31 was $1.04M, a 4.48% decline year-over-year.
- Dimension Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2016 was $814.00K, a 29.09% decline from fiscal 2015.
- Dimension Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2015 was $1.15M, a 46.24% increase from fiscal 2014.
- Dimension Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2014 was $785.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$380.00K derived: sum of 2 quarters · filed 2017-11-06 | -$1.34M 10-Q · filed 2017-11-06 | -$292.00K derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | -$76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$1.03M 10-Q · filed 2017-08-08 | $12.00K derived: sum of 3 quarters · filed 2017-08-08 | $967.00K derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | -$957.00K 10-Q · filed 2017-05-10 | $88.00K derived: sum of 2 quarters · filed 2017-05-10 | $1.04M derived: sum of 3 quarters · filed 2017-11-06 | -$567.00K derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $2.00M derived: sum of 2 quarters · filed 2017-11-06 | $390.00K derived: sum of 3 quarters · filed 2017-11-06 | $814.00K 10-K · filed 2017-03-09 |
| 2016-09-30 | $955.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$655.00K derived: sum of 2 quarters · filed 2017-11-06 | -$231.00K 10-Q · filed 2017-11-06 | $863.00K derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$1.19M 10-Q · filed 2017-08-08 | -$92.00K derived: sum of 3 quarters · filed 2017-08-08 | -$1.02M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $424.00K 10-Q · filed 2017-05-10 | $1.52M derived: sum of 2 quarters · filed 2017-05-10 | $592.00K derived: sum of 3 quarters · filed 2017-05-10 | $2.36M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $168.00K derived: sum of 2 quarters · filed 2017-03-09 | $1.94M derived: sum of 3 quarters · filed 2017-03-09 | $1.15M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$926.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $845.00K derived: sum of 2 quarters · filed 2016-11-10 | $54.00K 10-Q · filed 2016-11-10 | $188.00K derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $980.00K 10-Q · filed 2016-08-11 | $1.11M derived: sum of 3 quarters · filed 2017-03-09 | |
| 2015-03-31 | -$791.00K 10-Q · filed 2016-05-12 | -$657.00K derived: sum of 2 quarters · filed 2017-03-09 | ||
| 2014-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $785.00K 10-K · filed 2017-03-09 | ||
| 2014-09-30 | $651.00K 10-Q · filed 2015-12-04 | |||
| 2013-12-31 | $1.02M 10-K · filed 2016-03-24 |